REDUCED INTENSITY/NON-MYELOABLATIVE ALLOGRAFTING FOR HIGH RISK CHRONIC LYMPHOCYTIC LEUKEMIA

被引:0
|
作者
Giaccone, L. [1 ]
Sorasio, R. [1 ]
Fiore, F. [1 ]
Bergui, L. [1 ]
Resta, I [1 ]
Omede, P. [1 ]
Caltagirone, S. [1 ]
Massaia, M. [1 ]
Boccadoro, M. [1 ]
Bruno, B. [1 ]
机构
[1] Univ Torino, Azienda Osped San Giovanni Battista, Div Ematol, Turin, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P148
引用
收藏
页码:S99 / S99
页数:1
相关论文
共 50 条
  • [41] Non-myeloablative allogeneic stem cell transplantation for the treatment of patients with chronic myeloid leukemia.
    Slavin, S
    Nagler, A
    Shapira, M
    Aker, M
    Or, R
    BLOOD, 2000, 96 (11) : 203A - 203A
  • [42] Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia
    Ruiz-Argüelles, GJ
    Gómez-Almaguer, D
    López-Martinez, B
    Cantú-Rodriguez, OG
    Jaime-Pérez, JC
    González-Llano, O
    HAEMATOLOGICA, 2002, 87 (08) : 894 - 896
  • [43] Non-myeloablative allografting from HLA-identical sibling donors for treatment of CML.
    Kerbauy, FR
    Lange, T
    Gooley, T
    Shizuru, J
    Radich, J
    Maloney, DG
    Agura, E
    Bruno, B
    Epner, E
    Chauncey, T
    Blume, K
    Storb, R
    Niederwieser, D
    Sandmaier, BM
    BLOOD, 2004, 104 (11) : 637A - 637A
  • [44] The role of allogeneic hematopoietic cell transplantation with non-myeloablative conditioning in chronic myeloid leukemia.
    Gurman, G
    Arat, M
    Soydan, E
    Dalva, K
    Ilhan, O
    Uysal, A
    Beksac, M
    BLOOD, 2001, 98 (11) : 375B - 376B
  • [45] Results of a non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia.
    Ruiz-Argüelles, GJ
    Gómez-Almaguer, D
    López-Martínez, B
    Cantú-Rodríguez, OG
    Jaime-Pérez, JC
    González-Llano, O
    Herrera-Garza, JL
    BLOOD, 2002, 100 (11) : 453B - 454B
  • [46] Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases
    Satwani, Prakash
    Morris, Erin
    Bradley, M. Brigid
    Bhatia, Monica
    van de Ven, Carmella
    Cairo, Mitchell S.
    PEDIATRIC BLOOD & CANCER, 2008, 50 (01) : 1 - 8
  • [47] Reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia: related donor and umbilical cord allografting
    McClune, Brian L.
    Defor, Todd
    Brunstein, Claudio
    Vogel, Rachel I.
    Majhail, Navneet S.
    Bachanova, Veronika
    Burns, Linda J.
    Slungaard, Arne
    Weisdorf, Daniel J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (02) : 273 - 275
  • [48] OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDERGOING NON-MYELOABLATIVE ALLOGENIC STEM CELL TRANSPLANTATION AFTER TREATMENT WITH THE BRUTON TYROSINE KINASE INHIBITOR IBRUTINIB
    Ramdohr, F.
    Franke, G. -N.
    Jentzsch, M.
    Poenisch, W.
    Michael, C.
    Heyn, S.
    Wang, S. -Y.
    Behre, G.
    Leiblein, S.
    Schwind, S.
    Niederwieser, D.
    Vucinic, V.
    HAEMATOLOGICA, 2017, 102 : 861 - 861
  • [49] Alemtuzumab Use and Survival After Reduced Intensity Allogeneic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia (CLL)
    Ding, Wei
    Shanafelt, Tait D.
    Rabe, Kari
    Call, Timothy G.
    Zent, Clive S.
    Kay, Neil
    Inwards, David James
    Bowen, Deborah
    Litzow, Mark R.
    Slager, Susan L.
    Schwager, Susan
    Hogan, William J.
    BLOOD, 2011, 118 (21) : 1776 - 1776
  • [50] Comparison of non-myeloablative and reduced-intensity allogeneic stem cell transplantation in older patients with myelodysplastic syndromes
    Jentzsch, Madlen
    Doehring, Christine
    Linke, Richard
    Hille, Andrea
    Grimm, Juliane
    Poenisch, Wolfram
    Vucinic, Vladan
    Franke, Georg-Nikolaus
    Behre, Gerhard
    Niederwieser, Dietger
    Schwind, Sebastian
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (12) : 1344 - 1352